4.6 Article

Validation of Metabolic Alterations in Microscale Cell Culture Lysates Using Hydrophilic Interaction Liquid Chromatography (HILIC)-Tandem Mass Spectrometry-Based Metabolomics

期刊

PLOS ONE
卷 11, 期 4, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0154416

关键词

-

资金

  1. National Institutes of Health [R01 CA163649]
  2. American Association for Cancer Research (AACR)-Pancreatic Cancer Action Network (PanCAN) Career Development Award [30-20-25-SING]
  3. Specialized Programs for Research Excellence (SPORE) [2P50 CA127297]
  4. Pancreatic Tumor Microenvironment Research Network [U54, CA163120]
  5. Cancer Center support grant [P30 CA036727]

向作者/读者索取更多资源

By standard convention, in order to increase the efficacy of metabolite detection from cell culture lysates, metabolite extracts from a large quantity of cells are utilized for multiple reaction monitoring-based metabolomic studies. Metabolomics from a small number of cell extracts offers a potential economical alternative to increased cell numbers, in turn increasing the utility of cell culture-based metabolomics. However, the effect of reduced cell numbers on targeted metabolomic profiling is relatively unstudied. Considering the limited knowledge available of the feasibility and accuracy of microscale cell culture metabolomics, the present study analyzes differences in metabolomic profiles of different cell numbers of three pancreatic cancer cell lines. Specifically, it examines the effects of reduced cell numbers on metabolite profiles by obtaining extracts either directly from microscale culture plates or through serial dilution of increased numbers of cellular metabolite extracts. Our results indicate reduced cell numbers only modestly affect the number of metabolites detected (93% ofmetabolites detected in cell numbers as low as 10(4) cells and 97% for 10(5) cells), independent of the method used to obtain the cells. However, metabolite peak intensities were differentially affected by the reduced cell numbers, with some peak intensities inversely proportional to the cell numbers. To help eliminate such potential inverse relationships, peak intensities for increased cell numbers were excluded from the comparative analysis. Overall, metabolite profiles from microscale culture plates were observed to differ from the serial dilution samples, which may be attributable to the medium-to-cell-number ratios. Finally, findings identify perturbations in metabolomic profiling for cellular extracts from reduced cell numbers, which offer future applications in microscale metabolomic evaluations.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis

Ryan J. King, Surendra K. Shukla, Chunbo He, Enza Vernucci, Ravi Thakur, Kuldeep S. Attri, Aneesha Dasgupta, Nina V. Chaika, Scott E. Mulder, Jaime Abrego, Divya Murthy, Venugopal Gunda, Camila G. Pacheco, Paul M. Grandgenett, Audrey J. Lazenby, Michael A. Hollingsworth, Fang Yu, Kamiya Mehla, Pankaj K. Singh

Summary: Metabolic alterations play a crucial role in regulating cancer aggressiveness and immune responses. This study found that elevated expression of CD73, an enzyme involved in generating adenosine, is associated with increased aggressiveness in pancreatic ductal adenocarcinoma (PDAC). Inhibiting CD73 expression led to reduced tumor growth and myeloid-derived suppressor cells (MDSC) in PDAC mouse models. Furthermore, CD73 knockdown resulted in increased IFN-gamma expression by intratumoral CD4(+) and CD8(+) T cells and decreased GM-CSF levels. Depletion of CD4(+) T cells, but not CD8(+) T cells, abolished the beneficial effects of CD73 reduction. Overall, targeting the adenosine axis presents a promising therapeutic strategy for enhancing the immune response against PDAC.

ONCOGENE (2022)

Review Immunology

The cholesterol pathway: impact on immunity and cancer

Ryan J. King, Pankaj K. Singh, Kamiya Mehla

Summary: Cholesterol plays a role in cancer, atherosclerosis, and autoimmunity by modulating the immune system. Manipulating cholesterol metabolism may improve immunotherapy responses in cancer treatment. It can have both proinflammatory and anti-inflammatory effects in mammals, acting through various immune cell types depending on the context. Understanding the mechanisms of cholesterol-related metabolites can enhance our knowledge of their functions and effects on the immune system, leading to the development of better therapeutic strategies.

TRENDS IN IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Visceral adipose tissue remodeling in pancreatic ductal adenocarcinoma cachexia: the role of activin A signaling

Pauline C. Xu, Mikyoung You, Seok-Yeong Yu, Yi Luan, Maya Eldani, Thomas C. Caffrey, Paul M. Grandgenett, Kelly A. O'Connell, Surendra K. Shukla, Chandramohan Kattamuri, Michael A. Hollingsworth, Pankaj K. Singh, Thomas B. Thompson, Soonkyu Chung, So-Youn Kim

Summary: This study found that elevated activin A levels were associated with remodeling of visceral adipose tissue in PDAC patients, characterized by decreased adipocyte diameter and increased fibrotic deposition, without changes in expression of thermogenic marker UCP1.

SCIENTIFIC REPORTS (2022)

Article Biochemistry & Molecular Biology

Ubiquitous Aberration in Cholesterol Metabolism across Pancreatic Ductal Adenocarcinoma

Venugopal Gunda, Thiago C. Genaro-Mattos, Jyoti B. Kaushal, Ramakanth Chirravuri-Venkata, Gopalakrishnan Natarajan, Kavita Mallya, Paul M. Grandgenett, Karoly Mirnics, Surinder K. Batra, Zeljka Korade, Satyanarayana Rachagani

Summary: This study investigates the significance and consistency of the cholesterol synthesis pathway in pancreatic cancer through the use of preclinical models, in vitro analysis, and clinical specimens, revealing aberrations in sterol metabolite intermediates and related genes.

METABOLITES (2022)

Article Nutrition & Dietetics

The effect of gastric acid suppression on probiotic colonization in a double blinded randomized clinical trial

Gulshan Singh, Yeneneh Haileselassie, Leah Briscoe, Lawrence Bai, Akshar Patel, Elvi Sanjines, Steven Hendler, Pankaj K. Singh, Nandita R. Garud, Berkeley N. Limketkai, Aida Habtezion

Summary: This study found that the use of proton pump inhibitors (PPIs) can disrupt the gut microbiota, but probiotic intervention can mitigate these changes. Additionally, PPIs enhance the colonization of certain probiotic bacterial species. Therefore, combining PPIs with probiotics may be a beneficial strategy.

CLINICAL NUTRITION ESPEN (2022)

Article Biochemistry & Molecular Biology

The human AP-endonuclease 1 (APE1) is a DNA G-quadruplex structure binding protein and regulates KRAS expression in pancreatic ductal adenocarcinoma cells

Suravi Pramanik, Yingling Chen, Heyu Song, Irine Khutsishvili, Luis A. Marky, Sutapa Ray, Amarnath Natarajan, Pankaj K. Singh, Kishor K. Bhakat

Summary: This study identifies a novel role for the protein APE1 in regulating stable G4 formation and KRAS expression in PDAC, suggesting that G4 structures could be potential prognostic markers and therapeutic targets for PDAC.

NUCLEIC ACIDS RESEARCH (2022)

Article Biochemistry & Molecular Biology

Temporal analysis of melanogenesis identifies fatty acid metabolism as key skin pigment regulator

Farina Sultan, Reelina Basu, Divya Murthy, Manisha Kochar, Kuldeep S. Attri, Ayush Aggarwal, Pooja Kumari, Pooja Dnyane, Jyoti Tanwar, Rajender K. Motiani, Archana Singh, Chetan Gadgil, Neel Sarovar Bhavesh, Pankaj K. Singh, Vivek T. Natarajan, Rajesh S. Gokhale

Summary: This study investigates the temporal dynamics of melanogenesis and identifies three dominant phases of metabolic and transcriptional reprogramming. The findings suggest that fatty acid metabolism could be a potential therapeutic target for the treatment of various hyperpigmentary cutaneous diseases.

PLOS BIOLOGY (2022)

Article Multidisciplinary Sciences

Exploring the metabolic landscape of pancreatic ductal adenocarcinoma cells using genome-scale metabolic modeling

Mohammad Mazharul Islam, Andrea Goertzen, Pankaj K. Singh, Rajib Saha

Summary: In this study, a highly curated PDAC genome-scale metabolic model was reconstructed and used to explore the unique metabolic traits of PDAC. New therapeutic targets were identified, providing a better understanding of the metabolic vulnerabilities in PDAC and potential guidance for the development of novel therapeutic strategies.

ISCIENCE (2022)

Article Oncology

Ecdysoneless Overexpression Drives Mammary Tumorigenesis through Upregulation of C-MYC and Glucose Metabolism

Bhopal C. Mohapatra, Sameer Mirza, Aditya Bele, Channabasavaiah B. Gurumurthy, Mohsin Raza, Irfana Saleem, Matthew D. Storck, Aniruddha Sarkar, Sai Sundeep Kollala, Surendra K. Shukla, Siddesh Southekal, Kay-Uwe Wagner, Fang Qiu, Subodh M. Lele, Mansour A. Alsaleem, Emad A. Rakha, Chittibabu Guda, Pankaj K. Singh, Robert D. Cardiff, Hamid Band, Vimla Band

Summary: Ecdysoneless (ECD) protein is overexpressed in breast cancer and its overexpression predicts shorter survival in patients. In a mouse study, inducible overexpression of ECD led to mammary hyperplasia, pre-neoplastic lesions, heterogeneous tumors, and lung metastasis. ECD overexpression promoted epithelial to mesenchymal transition and cancer stem cell characteristics, and its oncogenic effects were mediated through regulation of c-MYC-mediated glucose metabolism.

MOLECULAR CANCER RESEARCH (2022)

Article Biochemistry & Molecular Biology

MARK2 regulates chemotherapeutic responses through class IIa HDAC-YAP axis in pancreatic cancer

Yongji Zeng, Ling Yin, Jiuli Zhou, Renya Zeng, Yi Xiao, Adrian R. Black, Tuo Hu, Pankaj K. Singh, Feng Yin, Surinder K. Batra, Fang Yu, Yuanhong Chen, Jixin Dong

Summary: This study identifies MARK2 as a critical regulator for paclitaxel chemosensitivity in PDAC and shows that it controls mitotic progression and paclitaxel cytotoxicity by regulating class IIa HDACs. Inhibition of MARK2 or HDACs enhances paclitaxel cytotoxicity and overcomes chemoresistance. The findings suggest that the MARK2-HDAC axis could be a potential target for overcoming chemoresistance in PDAC.

ONCOGENE (2022)

Article Oncology

ENT1 blockade by CNX-774 overcomes resistance to DHODH inhibition in pancreatic cancer

Nicholas J. Mullen, Ravi Thakur, Surendra K. Shukla, Nina Chaika, Sai Sundeep Kollala, Dezhen Wang, Chunbo He, Yuki Fujii, Shikhar Sharma, Scott E. Mulder, David B. Sykes, Pankaj K. Singh

Summary: In this study, we identified CNX-774 as a previously uncharacterized ENT1 inhibitor that could sensitize pancreatic cancer cell lines to the DHODH inhibitor brequinar (BQ). Our results also suggest that N-acetylneuraminic acid accumulation could serve as a potential marker for the therapeutic efficacy of DHODH inhibitors.

CANCER LETTERS (2023)

Editorial Material Oncology

LXR Signaling-Mediated Cholesterol Metabolism Reprogramming Regulates Cancer Cell Metastasis

Pankaj K. Singh, Kamiya Mehla

CANCER RESEARCH (2023)

Review Oncology

Nucleotide metabolism: a pan-cancer metabolic dependency

Nicholas J. J. Mullen, Pankaj K. K. Singh

Summary: Metabolic alterations, specifically the augmented synthesis and use of nucleotide triphosphates, are crucial for cancer cells and contribute to their aggressive behaviors and resistance to therapies. Upregulation of nucleotide biosynthesis is a prerequisite for cancer initiation and progression. Despite the potential of nucleotide synthesis inhibitors, their full efficacy has not been realized. This review discusses recent studies on the diverse roles of hyperactive nucleotide metabolism in cancer and explores opportunities for combination therapies to target these pathways effectively.

NATURE REVIEWS CANCER (2023)

Article Chemistry, Medicinal

Potent and Specific Activators for Mitochondrial Sirtuins Sirt3 and Sirt5

Benjamin Suenkel, Sergio Valente, Clemens Zwergel, Sandra Weiss, Elisabetta Di Bello, Rossella Fioravanti, Michele Aventaggiato, Joao A. Amorim, Neha Garg, Surinder Kumar, David B. Lombard, Tuo Hu, Pankaj K. Singh, Marco Tafani, Carlos M. Palmeira, David Sinclair, Antonello Mai, Clemens Steegborn

Summary: Sirtuins, a group of NAD+-dependent protein deacylases, play important roles in metabolic regulation and aging-related diseases. This study identifies 1,4-dihydropyridine-based compounds as potential activators for Sirtuin isoforms, including pan activators and specific stimulators for Sirt3 and Sirt5. These compounds can enhance turnover of peptide and protein substrates and activate cellular pathways such as apoptosis and electron transport chain.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

暂无数据